134 related articles for article (PubMed ID: 32251004)
1. Valproate-Associated Isolated Serum Creatine Kinase Elevation.
Gokcay H; Kirlioglu SS; Balcioglu YH
Am J Ther; 2022 Nov-Dec 01; 29(6):e653-e655. PubMed ID: 32251004
[No Abstract] [Full Text] [Related]
2. Confusion, Rigidity, and Elevated Creatine Phosphokinase: Atypical Neuroleptic Malignant Syndrome Possibly Associated With Clozapine and Sodium Valproate Use.
Uvais NA; Moideen S; Anver PC
Prim Care Companion CNS Disord; 2022 Sep; 24(5):. PubMed ID: 36179364
[No Abstract] [Full Text] [Related]
3. [Acute liver necrosis caused by valproate].
Zäh W; Rengeling M; Rühl G; Hackenberg K
Dtsch Med Wochenschr; 1985 Jun; 110(24):956-9. PubMed ID: 3922731
[TBL] [Abstract][Full Text] [Related]
4. Catatonia and CPK elevation in neurosyphilis: role of plural pharmacodynamic mechanisms.
Lauterbach EC; Norris BK; Carter WG; Shillcutt SD
Psychopharmacol Bull; 2009; 42(4):53-63. PubMed ID: 20581793
[TBL] [Abstract][Full Text] [Related]
5. Decreased serum carnitine in valproate induced Reye syndrome.
Böhles H; Richter K; Wagner-Thiessen E; Schäfer H
Eur J Pediatr; 1982 Nov; 139(3):185-6. PubMed ID: 6819143
[TBL] [Abstract][Full Text] [Related]
6. Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics.
Ladds B; Thomas P; Mejia C; Hauser D
Am J Psychiatry; 2009 Jan; 166(1):114-5. PubMed ID: 19122020
[No Abstract] [Full Text] [Related]
7. Clinical and pathophysiological characteristics of valproate-induced pleural effusion.
Tryfon S; Papadopoulou E; Saroglou M; Vlachopoulos D; Georgopoulou A; Serasli E; Ismailos G
Clin Toxicol (Phila); 2021 Oct; 59(10):869-876. PubMed ID: 34259092
[TBL] [Abstract][Full Text] [Related]
8. Pancreatitis with normal serum amylase associated with sodium valproate: a case report.
Otusbo S; Huruzono T; Kobae H; Yoshimi S; Miyata K
Brain Dev; 1995; 17(3):219-21. PubMed ID: 7573766
[TBL] [Abstract][Full Text] [Related]
9. [A case report of valproate encephalopathy].
Miyamoto T; Miyamoto M; Hirata K; Katayama S
Rinsho Shinkeigaku; 1999 Oct; 39(10):1075-7. PubMed ID: 10655774
[TBL] [Abstract][Full Text] [Related]
10. Use of intravenous valproate in a patient with neuroleptic malignant syndrome.
Tadke RR; Suryavanshi P
J Neuropsychiatry Clin Neurosci; 2006; 18(1):131-2. PubMed ID: 16525085
[No Abstract] [Full Text] [Related]
11. Encephalopathy in an infant with infantile spasms: possible role of valproate toxicity.
Sivathanu S; Sampath S; Veerasamy M; Sunderkumar S
BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24810446
[TBL] [Abstract][Full Text] [Related]
12. Isolated increase in serum alkaline phosphatase with sodium valproate therapy.
McPherson GS; Jani BR
Ann Pharmacother; 1995 May; 29(5):539. PubMed ID: 7655142
[No Abstract] [Full Text] [Related]
13. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
Fassi G; Igoa A; Liste OA
Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
[TBL] [Abstract][Full Text] [Related]
14. Lessons learned from the discovery of sodium valproate and what has this meant to future drug discovery efforts?
Janković SM; Janković SV
Expert Opin Drug Discov; 2020 Nov; 15(11):1355-1364. PubMed ID: 32686964
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults.
Gill D; Derry S; Wiffen PJ; Moore RA
Cochrane Database Syst Rev; 2011 Oct; 2011(10):CD009183. PubMed ID: 21975791
[TBL] [Abstract][Full Text] [Related]
16. [Isolated hyperammonemia. A frequent consequence of treatment with sodium valproate].
Warter JM; Marescaux C; Rumbach L; Galmiche J; Micheletti G; Koehl C; Imler M
Nouv Presse Med; 1981 Nov; 10(41):3406-7. PubMed ID: 6795590
[No Abstract] [Full Text] [Related]
17. An effective assessment of valproate sodium-induced hepatotoxicity with UPLC-MS and (1)HNMR-based metabonomics approach.
Huo T; Chen X; Lu X; Qu L; Liu Y; Cai S
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():109-16. PubMed ID: 25168794
[TBL] [Abstract][Full Text] [Related]
18. Waddling Gait: A complication of valproate therapy and a thought beyond vitamin D deficiency.
Sharma A; Sinha S; Narang A; Chouhan DK; Gupta S
Sultan Qaboos Univ Med J; 2020 Feb; 20(1):e104-e108. PubMed ID: 32190378
[TBL] [Abstract][Full Text] [Related]
19. Valproate-induced panhypogammaglobulinemia.
Eom TH; Lee HS; Jang PS; Kim YH
Neurol Sci; 2013 Jun; 34(6):1003-4. PubMed ID: 22797722
[TBL] [Abstract][Full Text] [Related]
20. Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients.
Venkataraman V; Wheless JW
Epilepsy Res; 1999 Jun; 35(2):147-53. PubMed ID: 10372567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
